Phase 2
Completed N=74
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
Source: ClinicalTrials.gov NCT02038023 ↗Enrolled (actual)
74
Serious AEs
0.0%
Results posted
Jun 2018
Primary outcomePrimary: Percentage of Women Who Achieve Anemia Correction After a Single Dose of 1000mg of Low Molecular Weight Iron Dextran(INfeD). — 35; 11 Participants
Summary
To determine the percentage of women who achieve anemia correction after a single dose of 1000mg of low molecular weight iron dextran(infed).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Women Who Achieve Anemia Correction After a Single Dose of 1000mg of Low Molecular Weight Iron Dextran(INfeD). |
35; 11 | — |
| SECONDARY Serum Ferritin |
126.29 | — |
| SECONDARY Percent Transferrin Saturation |
22.64 | — |
| SECONDARY Safety as Measured by Number of Adverse Events |
6 | — |
Eligibility Criteria
Inclusion Criteria
- pregnant women intolerable to oral iron. hbg 200 cc blood loss)prior to delivery. women with documented history of allergy to more than one class of drug clinically significant anemia requiring therapy in the opinion of the obstetrician, in the first trimester.
Data sourced from ClinicalTrials.gov (NCT02038023). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.